Detalhe da pesquisa
1.
An interferon-free antiviral regimen for HCV after liver transplantation.
N Engl J Med
; 371(25): 2375-82, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25386767
2.
Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
N Engl J Med
; 370(17): 1594-603, 2014 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24720703
3.
Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection.
Ther Drug Monit
; 38(5): 640-5, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27310199
4.
Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir.
J Hepatol
; 63(1): 20-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25646891
5.
CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.
J Infect Dis
; 209(6): 922-30, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24179109
6.
HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.
J Virol
; 86(2): 1119-28, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22090117
7.
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures.
J Virol
; 86(12): 6416-26, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22491471
8.
Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing.
PLoS Pathog
; 7(6): e1002106, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21731496
9.
HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.
J Virol
; 85(19): 10189-200, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21813616
10.
Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.
Clin Infect Dis
; 52(7): 925-8, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21427401
11.
Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimens.
Antimicrob Agents Chemother
; 55(6): 2872-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21464253
12.
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.
J Infect Dis
; 201(6): 803-13, 2010 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20151839
13.
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.
J Infect Dis
; 200(11): 1724-8, 2009 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19874179
14.
Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.
Clin Infect Dis
; 48(5): 680-2, 2009 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19191657
15.
Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays.
Antimicrob Agents Chemother
; 53(11): 4686-93, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19687240
16.
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.
J Clin Microbiol
; 47(8): 2604-6, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19494074
17.
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject.
J Virol
; 82(16): 8210-4, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18495779
18.
Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210.
AIDS Res Hum Retroviruses
; 35(8): 691-697, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31099252
19.
Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy.
AIDS
; 21(1): 103-6, 2007 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-17148975
20.
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Clin Infect Dis
; 44(4): 591-5, 2007 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17243065